Veterinary Molecular Diagnostics Industry
Summary:
- The global veterinary molecular diagnostics market size reached USD 690.8 Million in 2023.
- The market is expected to reach USD 1,391.9 Million by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032.
- North America leads the market, accounting for the largest veterinary molecular diagnostics market share.
- Kits and reagents accounts for the majority of the market share in the product segment as they are essential for conducting a wide range of molecular diagnostic tests, offering convenience, accuracy, and consistency in veterinary diagnostics.
- Real time PCR holds the largest share in the veterinary molecular diagnostics industry.
- Companion animal remain a dominant segment in the market, on account of the growing pet ownership trend, coupled with increasing spending on advanced healthcare for pets, particularly in developed regions.
- Vector-borne diseases represents the leading disease type segment.
- Based on the end user, the market has been divided into veterinary hospitals, clinical laboratories, and research institutes.
- The rising awareness about animal health and preventive care among pet owners is a primary driver of the veterinary molecular diagnostics market.
- Increasing incidence of chronic diseases in animals, along with the expansion of veterinary diagnostic laboratories are reshaping the veterinary molecular diagnostics market.
Industry Trends and Drivers:
- Increasing prevalence of zoonotic diseases:
Zoonotic diseases, those transmitted from animals to humans, have been on the rise globally due to factors such as urbanization, deforestation, and increased human-animal interactions. This increase in zoonotic diseases has intensified the demand for molecular diagnostics in veterinary care, as timely and accurate detection is critical to controlling outbreaks. The precision of molecular diagnostics in detecting pathogens at the genetic level allows veterinarians to diagnose diseases faster and more accurately than traditional diagnostic methods. With molecular diagnostics, specific viral and bacterial infections, including emerging zoonoses such as avian influenza or Lyme disease, can be identified earlier, improving treatment outcomes and reducing the risk of transmission to humans. This growing threat of zoonotic diseases continues to drive the need for advanced veterinary diagnostics, encouraging investment in molecular tools that can keep pace with new and evolving pathogens.
- Technological advancements in molecular diagnostics:
The veterinary molecular diagnostics market is benefiting significantly from rapid advancements in technology. Innovations in PCR (Polymerase Chain Reaction) techniques, next-generation sequencing (NGS), and point-of-care diagnostics have made molecular testing more accessible, faster, and cost-effective. These technological improvements allow for the detection of multiple pathogens simultaneously, reducing the time needed to diagnose conditions in animals. The enhanced sensitivity and specificity of these tools ensure more accurate results, which are essential for guiding appropriate treatments and improving animal welfare. Additionally, the miniaturization of diagnostic devices and the development of portable, user-friendly equipment enable veterinarians to perform molecular tests even in remote areas. The ability to conduct high-precision tests quickly in the field has opened new avenues for veterinary care, especially in rural and agricultural regions where immediate diagnosis is critical.
- Growing pet ownership and increased spending on animal health:
Pet ownership has been steadily increasing worldwide, with more individuals treating pets as family members. This trend is particularly evident in developed countries, where pet owners are willing to invest in advanced healthcare solutions to ensure the well-being of their animals. As a result, there is growing demand for sophisticated veterinary diagnostics, including molecular testing, to detect and treat illnesses in pets. The rise of preventive healthcare practices in the veterinary field has also played a role in driving demand. Pet owners are increasingly opting for regular health screenings and diagnostic tests for their animals, which includes the use of molecular diagnostics to detect genetic predispositions to certain diseases or early-stage infections. This increased awareness about animal health, coupled with higher disposable incomes, has significantly boosted spending on veterinary services, fostering growth in the veterinary molecular diagnostics market.
For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/veterinary-molecular-diagnostics-market/requestsample
Veterinary Molecular Diagnostics Market Report Segmentation:
Breakup By Product:
- Kits and Reagents
- Instruments
- Software and Services
Kits and reagents dominate the market as they are essential, recurring consumables required for a wide range of molecular diagnostic tests, ensuring consistent demand.
Breakup By Technology:
- Real Time PCR
- Microarray
- DNA Sequencing
Real time PCR represents the largest segment on account of its high accuracy, speed, and ability to quantify pathogen loads in real time, making it essential for rapid and precise veterinary diagnostics.
Breakup By Animal Type:
- Companion Animal
- Livestock Animal
Companion animal holds the maximum number of shares due to increasing pet ownership, rising healthcare spending on pets, and growing demand for advanced diagnostic services to ensure their well-being.
Breakup By Disease Type:
- Vector-borne Diseases
- Respiratory Pathogens
- Diarrhea Pathogens
- Others
Vector-borne diseases dominate the market due to the widespread prevalence of diseases such as Lyme disease and heartworm, transmitted through vectors such as ticks and mosquitoes, which require advanced diagnostic tools for timely detection and treatment.
Breakup By End User:
- Veterinary Hospitals
- Clinical Laboratories
- Research Institutes
Based on the end user, the market has been divided into veterinary hospitals, clinical laboratories, and research institutes.
Breakup By Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America holds the leading position owing to a large market for veterinary molecular diagnostics driven by its advanced veterinary healthcare infrastructure, high pet ownership rates, and increased investment in animal health technologies.
Top Veterinary Molecular Diagnostics Market Leaders:
- Biochek B.V.
- bioMérieux SA
- HealthGene Corporation
- Heska Corporation
- IDEXX Laboratories Inc.
- INDICAL BIOSCIENCE GmbH
- Ingenetix GmbH
- NEOGEN Corporation
- Qiagen N.V
- Thermo Fisher Scientific Inc.
- Veterinary Molecular Diagnostics Inc.
- Zoetis Inc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
